Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-984-1 | CAS number: 112-55-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key data were identified to evaluate the acute oral and acute dermal toxicity potential of dodecane-1-thiol. Key read across data from octane-1-thiol and 1,1-dimethylheptanethiol (strucural analogs of dodecane-1-thiol) were available to evaluate the acute inhalation toxicity potential. The key acute paramaters are presented below:
• Acute oral LD50: >5000 mg/kg bw
• Acute Inhalation LC50: >7.04 mg/L (based on 1,1-dimethylheptanethiol)
• Acute Dermal LD50: >2000 mg/kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Dose descriptor:
- LC50
- Value:
- 7.04 mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Acute Oral Toxicity
One key study was identified to evaluate the acute oral toxicity potential of dodecane-1-thiol.
In a key acute toxicity study (Latven 1977; Klimisch score = 2), male WBS/W rats (10/dose) were orally administered (via gavage) a single dose of dodecane-1-thiol at 5000 mg/kg bw. The animals were subsequently observed for a period of 14 days. No mortalities were observed through the study period. Significant daily body weight losses were observed in all test animals for the first three to four days post-treatment. However, all animals exhibited complete recovery by days six to eleven post-treatment. Based on the lack of mortality and treatment-related adverse systemic effects, the acute oral LD50 for dodecane-1-thiol was determined to be >5000 mg/kg bw.
Acute Inhalation Toxicity
No key studies were identified for dodecane-1-thiol. Two key read across acute inhalation toxicity studies that evaluated octane-1-thiol and 1,1-dimethylheptanethiol were identified.
In a key read across acute inhalation toxicity study (Collins, 1986; Klimisch score = 2), young adult Sprague-Dawley rats (5/sex) were exposed (head only), to 3.10 mg/L octane-1-thiol for 4.5 hours. Animals were subsequently observed for a period of 14 days. No mortality was observed and no treatment-related macroscopic or microscopic changes were evident through the study period. Clinical signs such as ataxia, lethargy, salivation, lachrymation, and piloerection were observed immediately following exposure but disappeared by day 2 post-exposure. Gross necroscopy did not reveal any remarkable findings. Based on the lack of adverse systemic effects observed, the inhalation LC50 for octane-1-thiol was determined to be >3.10 mg/L.
In another key read across acute inhalation toxicity study (Collins, 1987; Klimisch score = 1), groups of Crl:CD(SD)BR strain rats (5/sex) were exposed via the inhalation route to 1,1-dimethylheptanethiol for 4 hours at a concentration of 7.04 mg/L. Animals were subsequently observed for a period of 14 days. No mortality was observed in either male or female mice through the study period. Clinical signs such as ataxia, piloerection, wet fur, and transient salivation were observed in treated animals. There were no treatment-related effects on body weight and gross necropsy did not reveal any remarkable findings. Based on the lack of mortality and adverse systemic toxicity effects, the acute inhalation LC50 for 1,1-dimethylheptanethiol was determined to be >7.04 mg/L.
Acute Dermal Toxicity
One key study was identified to evaluate the acute dermal toxicity potential of dodecane-1-thiol.
In an acute dermal toxicity study (Latven, 1977; Klimisch score = 2), six male albino rats were dermally exposed to dodecane-1-thiol at a dose of 2000 mg/kg bw. Animals were subsequently observed for a period of 7 days. All animals remained asymptomatic and gained body weight during the observation period. The acute dermal LD50 for dodecane-1-thiol was therefore determined to be >2000 mg/kg bw.
Justification for classification or non-classification
Based on evaluation of the acute oral, inhalation, and dermal toxicity data discussed above, dodecane-1-thiol does not meet the criteria for classification as an acute oral, inhalation, or dermal toxicant under EU Dangerous Substances Directive 67/548/EEC or CLP EU Regulation 1272/2008 because the LD(C)50 values reported for this substance exceed the upper discriminating threshold limits for classification defined in the regulations.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.